2024-11-15
From November 11 to 14, KHB, along with its subsidiary Tianlong and Technogenetics S.P.A. (TGS), showcased at MEDICA 2024 in Düsseldorf, Germany. As one of the world's most influential medical industry exhibitions, MEDICA serves as a critical platform for global healthcare networking and presenting leading-edge technologies and solutions.
A Strong Global Presence: Three Companies Uniting on the International Stage
This MEDICA marks the first time that KHB, Tianlong, and TGS have jointly exhibited overseas, presenting innovative solutions across Biochemistry, Immunology, Molecular diagnostics, and POCT. This collaboration demonstrates the group's powerful synergy in healthcare innovation and a shared global vision.
Market Focus: Compact Efficiency and Breakthrough Automation
The innovative products of KHB and Tianlong have garnered strong interest, particularly their compact instruments and all-in-one automated systems. These efficient, convenient devices have become "star products" on site.
The newly launched V150 Automated Chemiluminescence Immunoassay Analyzer by KHB has become a highlight in immunoassay diagnostics, recognized for its precision and fully automated operations. To further meet market demands, KHB is continuously expanding its range of CLIA analyzers with various throughput models. In the future, KHB will develop a more comprehensive test menu of CLIA, including TGS autoimmune testing items. This expanded offering will provide customers with more complete and efficient diagnostic solutions.
KHB's Benchtop Fully Automated Biochemistry Analyzer ZY-260, designed for flexible environments, also attracted extensive interest. The comprehensive biochemistry test menu and customizable instrument configurations have received widespread acclaim, aligning with clinical needs and supporting the continuous development of laboratories.
Tianlong's Biolum Pro ATP Hygiene Monitoring System, winner of the Red Dot Design Award, was another highlight. This lightweight handheld device delivers hygiene test results in just 10 seconds with high sensitivity, providing quick and precise solutions for food safety and medical applications. Customers noted its versatility for rapid hygiene assessments, tailored to a wide range of client needs.
A Fresh Approach: Celebrating Growth and Innovation Together
With continuous resource integration, KHB maximizes technical advantages in IVD, delivering multi-dimensional diagnostic support and one-stop solutions. The group's unified display at MEDICA combines Biochemistry and Immunology with Tianlong's Molecular Diagnostics and TGS's Autoimmune Detection Solutions. This integrated approach created a closed-loop solution that covers a full product line and all application scenarios. Customers praised the enhanced product lineup and market appeal, appreciating KHB's adaptability in meeting diverse needs.
In Biochemistry, KHB's expanding analyzer lineup meets a range of laboratory requirements, attracting significant international interest. Its precise market positioning and high-quality service provide flexible solutions for healthcare institutions of varying sizes. With a robust overseas support team, KHB ensures timely after-sales support, earning recognition for its product innovation and technical support. Many clients are enthusiastic about future collaborations to enhance diagnostic service quality and efficiency.
Several non-governmental organizations (NGOs) with longstanding partnerships with KHB made a special visit, engaging in in-depth discussions with our team. They also expressed high praise for our HIV Rapid Diagnostic Kit, with which we have collaborated multiple times. Moving forward, KHB will continue to expand its rapid diagnostic products, partnering globally to address public health challenges.
Global Expansion: Strengthening European Presence
MEDICA 2024 provides an excellent opportunity to showcase KHB and Tianlong's core strengths, paving the way for further expansion and strengthening client partnerships. As our global business continues to grow, KHB will keep enhancing its presence in the European market with advanced technology and localized service.
Looking ahead, KHB and its subsidiaries will continue to expand their global business footprint, deepen market penetration, and support clients worldwide in achieving more efficient and accurate diagnostics and treatment.